Genetically engineered mouse models of CCA include those based on frequent oncogenic alterations observed in humans, such as TP53, PTEN, and SMAD4 loss, and activation of KRAS, IDH, and NOTCH signaling. Here, TP53 is linked to cholangiocarcinoma.